packageBasiliximab

basiliximab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Basiliximab is an immunosuppressive monoclonal antibody used to prevent graft rejection in kidney transplantation. It is authorised in the European Union and used in transplant medicine, though it carries a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q418702 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:basiliximab
ATC codes:L04AC02
DrugBank:DB00074
Wikidata:Q418702
molar mass:143801 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown